文献速递血液透析通路

下肢透析通路通畅性的患者影响因素及决策评分工具

Patient Factors Impacting Dialysis Patency: A Tool to Guide Decision Making for Creation of Lower Extremity Arteriovenous Access.
PubMed 文献 · Ann Vasc Surg · 2025-08-14

基于Vascular Quality Initiative透析模块2011至2023年数据,回顾性分析1213例下肢透析通路患者,其中AVF 151例、AVG 1062例。AVG的1年次级通畅率低于AVF(74.3% vs 88.6%,P=0.013),但初级通畅率无显著差异。研究识别影响次级通畅丧失的因素并构建0-100分评分系统(Dialysp Patency Estimation score)辅助决策。

要点

  • 下肢AVG的1年次级通畅率显著低于AVF(74.3% vs 88.6%,P=0.013)。
  • 下肢AVF与AVG的1年初级通畅率无显著差异(60.5% vs 50.9%,P=0.068)。
  • 评分>56分提示1年次级通畅丧失风险接近100%,可辅助选择AVG患者。

核心结论

  • 下肢AVG的通畅性劣于AVF,但临床使用更普遍。
  • 构建的0-100分风险评分可预测1年次级通畅丧失,辅助筛选可能从下肢AVG获益的患者。

研究设计与样本

  • 回顾性队列研究,数据来自Vascular Quality Initiative透析模块2011至2023年。
  • 共纳入1213例下肢透析通路患者,AVF 151例(12.45%),AVG 1062例(87.5%)。
  • 采用单因素Kaplan-Meier和多因素回归分析,结局为总体生存及初级/次级通畅。
  • 对显著因素标准化并缩放构建评分,模型经内部验证后导入临床计算器。

主要发现

  • 1年初级通畅率为52.18%,次级通畅率为77.56%。
  • AVF与AVG的1年初级通畅率分别为60.5%和50.9%,差异无统计学意义(P=0.068)。
  • AVF与AVG的1年次级通畅率分别为88.6%和74.3%,AVG显著更差(P=0.013)。
  • 增加次级通畅丧失的因素包括住院时间、年龄、体重指数、外周血管疾病、糖尿病和既往AVF/AVG。

关键数值与推荐

  • 评分系统范围为0至100分,预测1年次级通畅丧失风险。
  • 评分>56分对应风险接近100%。
  • 风险分组:0-40低危,41-50中低危,51-55中高危,56-100高危。

临床怎么用

  • 可利用Dialysis Patency Estimation评分对拟行下肢透析通路的患者进行风险分层。
  • 评分高危患者(>56分)选择下肢AVG需谨慎评估获益与风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lower extremity access remains a last resort for many patients needing dialysis access. We sought to identify patient factors impacting lower extremity arteriovenous fistula (AVF) and arteriovenous graft (AVG) patency and create a clinical tool to help guide decision-making in these complex patients. METHODS: All patients in the Vascular Quality Initiative dialysis module undergoing lower extremity access creation from 2011 to 2023 were separated into 2 cohorts based off whether the access was AVF or AVG and retrospectively analyzed. Univariate Kaplan-Meier and multivariable regression analyses were conducted with outcomes being overall survival and primary/secondary patency. Significant factors were standardized and scaled to create scores for loss of secondary patency. The model was then internally validated and imported into a clinical calculator to generate a score that was predictive of loss of patency (the Dialysis Patency Estimation score). RESULTS: In addition, 1,213 patients underwent creation of lower extremity access from 2011 to 2023 with 151 (12.45%) AVF and 1,062 (87.5%) AVG. One-year primary patency was 52.18% and secondary patency was 77.56% No difference was seen with primary patency based on access type (AVF 60.5%/AVG 50.9%, P = 0.068); however, AVG had worse secondary patency (AVF 88.6%/AVG 74.3%, P = 0.013). Factors increasing loss of secondary patency included: length of stay, age, body mass index, peripheral vascular disease, diabetes, and prior AVF/AVG. These factors were standardized and scaled to create a scoring system of 0 to 100 to predict loss of secondary patency at 1 year, with a score of >56 being near 100% risk. This scoring system was separated into 4 groups to predict risk of loss of patency (0-40 = low risk, 41-50 = medium low risk, 51-55 = medium high risk, and 56-100 = high risk). CONCLUSION: Lower extremity AVG has inferior patency compared to AVF, but are more commonly placed. We have created a risk stratification score to determine which patients may benefit from a lower extremity AVG.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ebertz DP, Christy G, Bose S, et al. Patient Factors Impacting Dialysis Patency: A Tool to Guide Decision Making for Creation of Lower Extremity Arteriovenous Access. Ann Vasc Surg. 2025. PMID: 40818815. doi:10.1016/j.avsg.2025.08.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。